Kazia Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2015 - 2019
Operating Revenue	2.31	2.31	-	-	15.18	-	Upgrade
Other Revenue	0.2	0.17	0	0.01	-	0.99	Upgrade
Revenue	2.5	2.48	0	0.01	15.18	0.99	Upgrade
Revenue Growth (YoY)	248983.08%	248000.00%	-90.00%	-99.93%	1436.54%	-31.38%	Upgrade
Gross Profit	2.5	2.48	0	0.01	15.18	0.99	Upgrade
Selling, General & Admin	14.12	13.56	8.58	5.24	7.02	3.69	Upgrade
Research & Development	17.33	17.38	15.56	20.17	14.54	9.49	Upgrade
Other Operating Expenses	-	-	-	-0.02	-0	-0	Upgrade
Operating Expenses	31.45	30.94	24.15	25.39	21.56	13.18	Upgrade
Operating Income	-28.95	-28.46	-24.15	-25.38	-6.38	-12.19	Upgrade
Interest & Investment Income	0.03	0.01	0.02	0	0.04	0.07	Upgrade
Currency Exchange Gain (Loss)	-	-	-	-	-	0	Upgrade
Other Non Operating Income (Expenses)	-0.8	1.28	-	-	-	-	Upgrade
EBT Excluding Unusual Items	-29.72	-27.17	-24.12	-25.38	-6.34	-12.12	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	-	-0.17	Upgrade
Other Unusual Items	1.04	0.12	3.39	-	-2.57	-0.47	Upgrade
Pretax Income	-28.68	-27.05	-20.74	-25.38	-8.91	-12.77	Upgrade
Income Tax Expense	-0.27	-0.27	-0.27	-0.37	-0.48	-0.3	Upgrade
Earnings From Continuing Operations	-28.41	-26.78	-20.47	-25.01	-8.42	-12.47	Upgrade
Net Income	-28.41	-26.78	-20.47	-25.01	-8.42	-12.47	Upgrade
Net Income to Common	-28.41	-26.78	-20.47	-25.01	-8.42	-12.47	Upgrade
Shares Outstanding (Basic)	1	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	0	0	0	0	Upgrade
Shares Change (YoY)	54.04%	43.08%	39.12%	12.57%	61.08%	27.04%	Upgrade
EPS (Basic)	-39.86	-50.78	-55.53	-94.42	-35.78	-85.33	Upgrade
EPS (Diluted)	-39.86	-50.78	-55.53	-94.42	-35.80	-85.35	Upgrade
Free Cash Flow	-11.67	-9.58	-15.16	-22.76	-9.11	-8.81	Upgrade
Free Cash Flow Per Share	-16.37	-18.17	-41.12	-85.92	-38.71	-60.30	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-1156.36%	-1147.20%	-2414600.00%	-253840.00%	-42.01%	-1234.06%	Upgrade
Profit Margin	-1134.84%	-1079.32%	-2046500.00%	-250140.00%	-55.47%	-1261.75%	Upgrade
Free Cash Flow Margin	-466.04%	-386.17%	-1515600.00%	-227620.00%	-60.01%	-891.55%	Upgrade
EBITDA	-27.08	-26.59	-22.28	-23.52	-5.11	-11.11	Upgrade
EBITDA Margin	-	-	-	-	-33.68%	-	Upgrade
D&A For EBITDA	1.87	1.87	1.87	1.87	1.27	1.08	Upgrade
EBIT	-28.95	-28.46	-24.15	-25.38	-6.38	-12.19	Upgrade
EBIT Margin	-	-	-	-	-42.01%	-	Upgrade

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q